Long-term of 10 Years Results of a Prospective Longitudinal Study
- Conditions
- Type 2 Diabetes MellitusBlood Pressure
- Interventions
- Procedure: Blood pressure measurement based on HBP or CBP
- Registration Number
- NCT01557972
- Lead Sponsor
- Nagaoka Red Cross Hospital
- Brief Summary
Previous cross-sectional studies have demonstrated that blood pressure (BP) measurements at home (HBP) in the morning offer stronger predictive power for micro- and macrovascular complications in patients with type 1 and 2 diabetes than casual/clinic blood pressure measurements (CBP) (Kamoi K et al, 2002-2003). Further, a prospective, longitudinal study for 6 years in patients with type 2 diabetes also demonstrated that control of wakening-up HBP provides the stronger predictive power for the outcomes than that of CBP did (Kamoi et al, 2010).
However, it is not clear to show which of BP measurement provides the stronger predictive power for outcomes by comparing cumulative events over a longer time than 6 years. Therefore, the investigators examined which of HBP or CBP provides the stronger predictive power for outcomes in addition of renal anemia reported previously over 10 years in the patients with type 2 diabetes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 400
- After a detailed baseline examination, 400 Japanese subjects with type 2 diabetes reported previously are followed up for all-cause mortality and morbidity.
- Other than the above, patients judged inappropriate as the subjects of this study by the investigator
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1. Morning HP and NT Blood pressure measurement based on HBP or CBP Subjects based on HBP were divided into MH and MN patients 2. Clinic HP and NT Blood pressure measurement based on HBP or CBP Subjects based on CBP were divided into CH and CN patients
- Primary Outcome Measures
Name Time Method Death Average time is 10 years Number of participats not alive
- Secondary Outcome Measures
Name Time Method Macrovascular complications Average time is 10 years Microvascular complications including renal anemia Average time is 10 years
Trial Locations
- Locations (1)
Nagaoka Red Cross Hospital
🇯🇵Nagaoka, Niigata, Japan